A randomized clinical trial comparing Blue®m oral gel and autologous PRF membrane as adjuncts to surgical debridement in BRONJ/MRONJ patients.
Thirty-six BRONJ/MRONJ patients will be randomly allocated to receive either Blue®m oral gel or PRF membrane following surgical debridement, and healing outcomes will be evaluated clinically.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
36
Intraoperative application of Blue®m oral gel to the debrided surgical site before primary closure
Intraoperative placement of an autologous PRF membrane over the debrided surgical site before flap closure.
Faculty of Dentistry Mansoura University
Al Mansurah, Egypt
Complete mucosal healing (bone coverage)
Mucosal healing will be evaluated clinically by direct inspection of the surgical site.
Time frame: 12 weeks post-intervention
Soft-Tissue Healing
Soft tissue healing will be assessed using the Landry Healing Index, measured on a 5-point scale.
Time frame: - One week after intervention - 2 weeks after intervention - 4 weeks after intervention - 12 weeks after intervention
Postoperative pain
Pain assessment will be evaluated using the Numeric Rating Scale (NRS), measured on a 0-10 scale.
Time frame: - 1 week postoperatively - 4 weeks postoperatively
Hard Tissue
Bone density will be measured using CBCT at buccal, palatal, and apical aspects at coronal, middle, and apical levels, and the average value will be recorded.
Time frame: - Preoperatively - 12 weeks postoperative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.